FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides)
Public ClinicalTrials.gov record NCT02448381. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Determine the Efficacy of Topical SGX301 (Synthetic Hypericin) and Fluorescent Bulb-Light Irradiation for the Treatment of Cutaneous T-Cell Lymphoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the use of SGX301, a topical photosensitizing agent, to treat patients with patch/plaque phase cutaneous T-cell lymphoma (mycosis fungoides).
Study identification
- NCT ID
- NCT02448381
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 169 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2015 (Actual)
- Primary completion
- Jun 2020 (Actual)
- Completion
- Nov 2020 (Actual)
- Last update posted
- Apr 15, 2022
2015 – 2020
United States locations
- U.S. sites
- 33
- U.S. states
- 21
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama Birmingham | Birmingham | Alabama | 35294 | — |
| University of Arizona | Phoenix | Arizona | 85004 | — |
| Mayo Clinic | Scottsdale | Arizona | 85259 | — |
| University of Arkansas | Little Rock | Arkansas | 72205 | — |
| Stanford University | Palo Alto | California | 94304 | — |
| Therapeutics Clinical Research | San Diego | California | 92123 | — |
| Olympian Clinical Research | Clearwater | Florida | 33756 | — |
| Leon Medical Research | Miami | Florida | 33015 | — |
| Medical Professional Clinical Research | Miami | Florida | 33165 | — |
| University of South Florida | Tampa | Florida | 33612 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Rush University | Chicago | Illinois | 60612 | — |
| Dawes Fretzin Dermatology Group | Indianapolis | Indiana | 46256 | — |
| Tulane University | New Orleans | Louisiana | 70112 | — |
| University of Maryland | Baltimore | Maryland | 21201 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Washington University | St Louis | Missouri | 63110 | — |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| Rochester Skin Lymphoma Medical Group | Fairport | New York | 14450 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Stony Brook Medicine | Stony Brook | New York | 11790 | — |
| PMG Research of Wilmington | Wilmington | North Carolina | 28401 | — |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | — |
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Jefferson Dermatology | Philadelphia | Pennsylvania | 19107 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29424 | — |
| Vanderbilt University | Nashville | Tennessee | 37212 | — |
| MD Anderson | Houston | Texas | 77030 | — |
| Austin Institute for Clinical Research | Pflugerville | Texas | 78660 | — |
| INOVA Schar Cancer Institute | Fairfax | Virginia | 22031 | — |
| Virginia Clinical Research | Norfolk | Virginia | 23502 | — |
| Seattle Care Cancer Center | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02448381, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 15, 2022 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02448381 live on ClinicalTrials.gov.